This interview also features the comments of Brendan Fitzpatrick, Vice President Finished Goods Manufacturing. Ms. Murphy, your transition to your…

Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.”…

To what extent do you believe Ireland has been successful in building the knowledge economy it set out to create during the 1980's? I think we have…

You noted that, in the ‘old days’, the pharma business had the following characteristics: first of all, it was a molecule-driven business,…

Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin.…

Prof. Ferguson, when you were recently appointed to direct SFI, local newspapers ran headlines such as “New SFI head to drive economic impact…

If we had to run shy of being competitive, I don’t believe that we would be driving in the right lane in this industry.'

Mr. Leahy, you worked for Servier for nearly a decade before joining Takeda. What have been the chief differences you have noticed between the…

Novo Nordisk is primarily known as the premier global diabetes player—so let us begin by examining the realities of diabetes in Ireland. In 2012,…

Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in…

You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market…

Celgene just announced very impressive second quarter results for its global operations, with a 38% increase in revenue partly led by strong growth in…